Skip to Main Content
Get Opthea Updates
Company
Company Overview
Management Team
Board of Directors
Medical Advisory Board
Clinical Advisory Board
Science
Opportunity
Technology / Mechanism
Pipeline Overview
Scientific Presentations
Clinical Trials
Wet AMD Trial: Phase 3
Wet AMD Trial: Phase 2B
Wet AMD Trial: Phase 1/2A
DME: Phase 1B/2A
Publications
Expanded Access Policy
Investors
News
Contact
Eyewire TV: Interview with Opthea CEO, Megan Baldwin,PhD
by
Samuel Nee
|
Oct 19, 2022
|
In The Media